These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4780481)

  • 1. [Possible dependence of the antifibrillatory action of inderal in experimental myocardial infarct on its effect on oxidation-reduction processes and the blood supply of the heart].
    Shargorodskiĭ BM; Kats IA
    Kardiologiia; 1973 Mar; 13(3):81-7. PubMed ID: 4780481
    [No Abstract]   [Full Text] [Related]  

  • 2. [The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply].
    Shargorodskii BM; Kats IA
    Kardiologiia; 1973 Mar; 13(3):81-7. PubMed ID: 4717189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of propranolol (Inderal)].
    Doshchitsin VL; Zharov EI; Arshakuni RO
    Kardiologiia; 1967 Oct; 7(10):59-67. PubMed ID: 4179686
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antifibrillatory activity of propranolol in experimental myocardial infarct and its cardiodepressive and hypotensive action].
    Urbanics R; Shargorodskiĭ BM; Kovacs A; Raĭskina ME
    Kardiologiia; 1980 Oct; 20(10):78-81. PubMed ID: 7441964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol and experimental myocardial infarction: substrate effects.
    Opie LH; Thomas M
    Postgrad Med J; 1976; 52 Suppl 4():124-32. PubMed ID: 787952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol on myocardial ultrastructure, mitochondrial function and high energy phosphates of isolated working rat hearts with coronary artery ligation.
    Edoute Y; Sanan D; Lochner A; Graney D; Kotze JC
    J Mol Cell Cardiol; 1981 Jul; 13(7):619-39. PubMed ID: 7277507
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
    Kenedi I; Losonci A
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):247-57. PubMed ID: 4143381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inderal (propanolol) and coronary circulation].
    Malcolm J; Waycott J
    Rev Med Liege; 1969 Apr; 24(8):352-3. PubMed ID: 5403430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the anti-arrhythmia effect of phosphocreatine in the acute stage of experimental myocardial infarction].
    Kryzhanovskiĭ SA; Vititnova MB; Kaverina NV; Bobkov IuG; Saks VA
    Kardiologiia; 1988 Nov; 28(11):100-3. PubMed ID: 3230761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental studies on 1-phenyl-2-1-phenylpropyl-3-amino proprane hydrochloride in dogs with experimental myocardial infarct].
    Manolov P; Chakurov S; Krustev D; Dikov N; Naumov G
    Eksp Med Morfol; 1973; 12(1):18-22. PubMed ID: 4772026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of propranolol (Inderal) on coronary circulation].
    Yusa T; Iwatsuki K
    Masui; 1967 Dec; 16(12):1064-71. PubMed ID: 5627085
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of propranolol on the fibrillation threshold and the period of vulnerability of cardiac ventricles under normal conditions and during acute coronary occlusion].
    Mishchenko IK; Gal'tseva NA
    Kardiologiia; 1978 Apr; 18(4):79-84. PubMed ID: 671973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a beta-adrenergic-blocking agent (propranolol) on systemic and coronary hemodynamics in dogs].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(18):1209-11. PubMed ID: 5971146
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies on the effects of propranolol and phenozybenzamine on the electrocardiogram and coronary blood flow.
    Hayase S; Ito H; Kondo Y; Imao T
    Isr J Med Sci; 1969; 5(4):515-8. PubMed ID: 5820468
    [No Abstract]   [Full Text] [Related]  

  • 16. The actions of histamine on the mammalian heart.
    Flacke W; Atanacković D; Gillis RA; Alper MH
    J Pharmacol Exp Ther; 1967 Feb; 155(2):271-8. PubMed ID: 6025518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Propranolol (Inderal) for the treatment of arrhythmias. Clinical experience mainly in open heart surgical cases].
    Koie H; Abe K; Tsushimi K; Muraoka R; Hikasa Y
    Nihon Geka Hokan; 1971 May; 40(1):99-105. PubMed ID: 5106426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
    Goldshteĭne GKh; Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nitroglycerin, dipyridamole, and propranolol on glycogen metabolism during coronary artery ligation in dogs.
    Ichihara K; Abiko Y
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():531-5. PubMed ID: 829648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in myocardial infarction.
    Grayson J
    Lancet; 1967 Apr; 1(7493):788-9. PubMed ID: 4164138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.